INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases R Beekhof, C van Alphen, AA Henneman, JC Knol, TV Pham, F Rolfs, ... Molecular systems biology 15 (4), e8250, 2019 | 79 | 2019 |
Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response NQ Liu, T De Marchi, AM Timmermans, R Beekhof, ... Molecular & Cellular Proteomics 13 (7), 1814-1827, 2014 | 54 | 2014 |
Phosphotyrosine-based phosphoproteomics for target identification and drug response prediction in AML cell lines C van Alphen, J Cloos, R Beekhof, DGJ Cucchi, SR Piersma, JC Knol, ... Molecular & Cellular Proteomics 19 (5), 884-899, 2020 | 32 | 2020 |
Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection M Labots, JC van der Mijn, R Beekhof, SR Piersma, RR de Goeij-de Haas, ... Journal of proteomics 162, 99-107, 2017 | 31 | 2017 |
Peptide-mediated ‘miniprep’isolation of extracellular vesicles is suitable for high-throughput proteomics JC Knol, I de Reus, T Schelfhorst, R Beekhof, M de Wit, SR Piersma, ... EuPA Open Proteomics 11, 11-15, 2016 | 30 | 2016 |
Proteomic analysis of miR-195 and miR-497 replacement reveals potential candidates that increase sensitivity to oxaliplatin in MSI/P53wt colorectal cancer cells D Poel, LNC Boyd, R Beekhof, T Schelfhorst, TV Pham, SR Piersma, ... Cells 8 (9), 1111, 2019 | 27 | 2019 |
Kinase inhibitor treatment of patients with advanced cancer results in high tumor drug concentrations and in specific alterations of the tumor phosphoproteome M Labots, TV Pham, RJ Honeywell, JC Knol, R Beekhof, ... Cancers 12 (2), 330, 2020 | 15 | 2020 |
.(2019) INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases R Beekhof, C van Alphen, AA Henneman, JC Knol, TV Pham, F Rolfs, ... Mol. Syst. Biol 15, e8250, 0 | 5 | |
Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer R Beekhof, A Bertotti, F Böttger, V Vurchio, F Cottino, ER Zanella, ... Science Translational Medicine 15 (709), eabm3687, 2023 | 3 | 2023 |
INKA, an integrative data analysis pipeline for phosphoproteomic inference of active phosphokinases TV Pham, R Beekhof, C van Alphen, JC Knol, AA Henneman, F Rolfs, ... bioRxiv, 259192, 2018 | 2 | 2018 |
Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho) proteomics H van der Wijngaart, R Beekhof, JC Knol, AA Henneman, ... Clinical Proteomics 20 (1), 49, 2023 | 1 | 2023 |
Prediction of response to sunitinib in patients with advanced renal cell carcinoma (RCC) using mass spectrometry-based (phospho) proteomics. H van der Wijngaart, R Beekhof, JC Knol, AA Henneman, ... Journal of Clinical Oncology 39 (15_suppl), e16556-e16556, 2021 | | 2021 |
Comparison of phosphoproteomic profiles in left-and right-sided colorectal cancers. T Buffart, R Beekhof, R van den Oord, RR de Haas, TV Pham, H Dekker, ... Journal of Clinical Oncology 37 (4_suppl), 582-582, 2019 | | 2019 |
Peptide-mediated ‘miniprep’isolation of extracellular vesicles for high-throughput proteomics; method evaluation and application in colon cancer CR Jimenez, M de Wit, JC Knol, I de Reus, T Schelfhorst, L Bishop-Currey, ... Cancer Research 76 (14_Supplement), 3885-3885, 2016 | | 2016 |
Mapping the metastatic colorectal cancer phospho-proteome for predicting response to cetuximab R Beekhof, M Labots, JC Knol, TRA Schelfhorst, N van Grieken, ... Cancer Research 76 (14_Supplement), 880-880, 2016 | | 2016 |
Mass spectrometry-based phosphoproteomics of tumor needle biopsies from patients (pts) with advanced solid tumors during treatment with protein kinase inhibitors. M Labots, R Beekhof, JC Knol, M Neerincx, RR de Haas, H Dekker, ... Journal of Clinical Oncology 34 (15_suppl), 11609-11609, 2016 | | 2016 |
Phosphoproteomics scaled-down to tumor biopsies for future TKI treatment selection M Labots, JC Van der Mijn, SR Piersma, RR De Haas, R Beekhof, ... Cancer Research 75 (15_Supplement), 2007-2007, 2015 | | 2015 |
Copyright 2014 by The American Society for Biochemistry and Molecular Biology, Inc. NQ Liu, T De Marchi, AM Timmermans, R Beekhof, A MAC | | 2012 |
Abbott, Derek, 852 Aljabr, Waleed, 793 Armstrong, Stuart D., 793 Arvan, Peter, 852 M Avino, JP Babeu, B Beadle, I Bederman, R Beekhof, B Bodenmiller, ... | | |
feasibility of phosphoproteomics measurements in tumor biopsies from patients with cancer M Labots, JC van der Mijn, R Beekhof, SR Piersma, RR de Goeij-de Haas, ... VU Research Portal, 61, 0 | | |